Head of Investor Relations
UNITED THERAPEUTICS Corp (UTHR)Equibles does not estimate personal net worth.
Get an email with a short summary when UNITED THERAPEUTICS Corp publishes a filing, an earnings call transcript or a press release.
Get UTHR alertsDewey Steadman is recorded as Head of Investor Relations at UNITED THERAPEUTICS Corp (UTHR). Dewey Steadman has spoken on 22 earnings calls across 1 company, most recently for UNITED THERAPEUTICS Corp on February 25, 2026. UNITED THERAPEUTICS Corp is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at UNITED THERAPEUTICS Corp includes Christopher Causey (Board Member), Christopher Patusky (Board Member), James Edgemond (Board Member) and 7 others.
“It is my pleasure to welcome you to the United Therapeutics Corporation fourth quarter 2025 corporate update webcast. Remarks today will include forward-looking statements representing our expectations or beliefs regarding future events.”
“It's my pleasure to welcome you to the United Therapeutics Corporation's Second Quarter 2025 Corporate Update Webcast. Remarks today will include forward-looking statements representing our expectations or beliefs regarding future events.”
“It is my pleasure to welcome you to the United Therapeutics Corporation first quarter 2025 corporate update webcast. Remarks today will include forward-looking statements representing our expectations or beliefs regarding future events.”
“It's my pleasure to welcome you to the United Therapeutics Fourth Quarter 2024 corporate update webcast. We marked today will include forward-looking statements representing our expectations or beliefs regarding future events.”
“It's my pleasure to welcome you to the United Therapeutics Corporation Third Quarter 2024 Earnings Webcast.”
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
